CCO Expert Recap

Update on Non Hodgkin’s Lymphoma

Source: CCO Independent Conference Coverage of the American Society of Hematology 2008 Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on Non Hodgkin’s Lymphoma

Program Director: Roy A. Beveridge, MD

Faculty:

Julie M. Vose, MD

CREDIT INFORMATION

Release Date: February 26, 2009

Expiration Date: February 25, 2010

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.5 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe recent findings on new treatment regimens and the prognostic value of minimal residual disease for patients with mantle cell lymphoma
Summarize the results of clinical trials investigating novel agents for the treatment of T-cell lymphoma
Evaluate new data on the efficacy and safety of novel immunotherapies for patients with non-Hodgkin’s lymphoma
Discuss the latest data on the use of agents targeting the B-cell receptor signaling pathway for the treatment of relapsed non-Hodgkin’s lymphoma

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.